RINVOQ

SMC Issues Positive Decision for Treatment with AbbVie’s RINVOQ®▼(upadacitinib) in Severe Active Rheumatoid Arthritis (RA)

Positive indication means upadacitinib will be available to those with previously treated severe active RA* SMC approval is based on data from pivotal Ph... Read More...

Healthcare Professional ONLY

This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors